中国神经再生研究(英文版) ›› 2018, Vol. 13 ›› Issue (8): 1396-1407.doi: 10.4103/1673-5374.235293

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

灯盏花乙素能保护氧糖剥夺的星型胶质细胞损伤及减轻局灶性缺血性脑损伤

  

  • 收稿日期:2018-06-19 出版日期:2018-08-15 发布日期:2018-08-15
  • 基金资助:

    中国国家自然科学基金项目(81303115, 81774042, 81771353),广东省自然科学基金项目(S2013040016915),广州市科技项目(201508020050, 201604020003),广州市珠江科技新星项目,中国博士后项目(BBK42913K09, 201003345, BBH429151701),广州中医药大学2017年高水平大学构建项目香港学者项目(A1-AFD018171Z11096),广东省中医院专项基金项目(YN2016MJ07, YN2015QN16, YN2015B2025

Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury

Jing-Bo Sun1, 2, 3, 4, Yan Li1, 2, 3, 4, Ye-Feng Cai1, 2, 3, 4, Yan Huang1, 2, 3, 4, Shu Liu5, Patrick KK Yeung6, Min-Zhen Deng1, 2, 3, 4, Guang-Shun Sun7, Prince LM Zilundu8, Qian-Sheng Hu7, Rui-Xin An8, Li-Hua Zhou8, Li-Xin Wang1, 2, 3, 4, Xiao Cheng1, 2, 3, 4   

  1. 1 Department of Neurology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China;
    2 Department of Second Institute of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China;
    3 Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, Guangdong Province, China;
    4 Guangdong Provincial Chinese Emergency Key Laboratory, Guangzhou, Guangdong Province, China;
    5 Department of Anatomy, An Hui Medical University, Hefei, Anhui Province, China;
    6 Department of Biomedical Sciences, The University of Hong Kong, Hong Kong Special Administrative Region, China;
    7 Department of Preventive Medicine, School of Public Health, Zhong Shan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province, China;
    8 Guangzhou Department of Anatomy, Zhong Shan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province, China
  • Received:2018-06-19 Online:2018-08-15 Published:2018-08-15
  • Contact: Xiao Cheng, Ph.D.,chengxiaolucky@126.com.
  • Supported by:

    This study was financially supported by the National Natural Science Foundation of China, No. 81303115, 81774042, 81771353;the Natural Science Foundation of Guangdong Province of China, No. S2013040016915; the Science and Technology Program of Guangzhou City of China, No. 201508020050, 201604020003; the Pearl River S & T Nova Program of Guangzhou, the Postdoctoral Foundation of China,No. BBK42913K09, 201003345, BBH429151701; a grant from the Hong Kong Scholar Program, Guangzhou University of TCM 2017 High Level University Construction Program, No. A1-AFD018171Z11096; a grant from the Specialty Program of Guangdong Province Hospital of Traditional Chinese Medicine of China, No. YN2016MJ07, YN2015QN16, YN2015B2025.

摘要:

灯盏花乙素是从中国云南特有物种灯盏花中分离得到的一种活性黄酮,具有抗炎、抗神经毒性、抗凋亡和抗氧化作用,已被用于临床治疗心脑血管疾病。然而,灯盏花乙素在脑缺血中介导神经保护的确切机制仍不清楚。为此,实验首先通过分子对接技术评估灯盏花乙素与NADPH氧化酶2之间的相互作用,证实灯盏花乙素选择性地以高亲和力与NADPH氧化酶2结合。然后利用从出生0-2d的SD大鼠大脑皮质中分离原代星形胶质细胞,以5%CO2无葡萄糖的DMEM培养基中温育2h,继而再灌注22h的方法模拟体外模拟脑缺血损伤,以2,10,50 μM灯盏花乙素预处理30min进行保护。以CCK8检测细胞活力,以western blot分析NADPH氧化酶2、缝隙连接蛋白43和caspase3的表达,以酶标仪测量活性氧水平,发现10和50μM灯盏花乙素预处理可明显提高氧糖剥夺再灌注诱导的星形胶质细胞的活力,降低损伤细胞中NADPH氧化酶2和caspase3的表达,增加缝隙连接蛋白43的表达,降低活性氧水平;实验还以线栓法建立脑缺血大鼠模型,造模前2h腹腔注射100mg/kg灯盏花乙素。以Bederson法评估神经功能缺损,以TTC染色测量脑梗死体积,以Western blot分析脑组织中NADPH氧化酶2和缝隙连接蛋白43的表达水平,以ELISA法检测脑组织中DNA、脂质及蛋白质氧化损伤的产物8-羟化脱氧鸟苷,4-羟基壬烯醛及3-硝基酪氨酸的水平,以免疫荧光双标染色检测caspase3和NeuN的共表达,结果可见灯盏花乙素预处理可改善局灶性脑缺血损伤大鼠的神经功能,缩小脑梗死体积,降低损伤侧脑组织中NADPH氧化酶2表达,减少脑组织中8-羟化脱氧鸟苷,4-羟基壬烯醛及3-硝基酪氨酸的水平,减少损伤半暗带中Caspase3与NeuN共表达;最后以NADPH氧化酶2抑制剂夹竹桃麻素对氧糖剥夺的星型胶质细胞损伤及局灶性脑缺血损伤大鼠模型进行干预,发现其也能显著增加体内外模型中缝隙连接蛋白43的表达,表明灯盏花乙素能保护氧糖剥夺的星型胶质细胞损伤及局灶性脑缺血损伤,其作用机制与下调脑缺血损伤引起的NADPH氧化酶2上调,增强缝隙连接蛋白43表达,对抗过氧化损伤及抗凋亡有关。

orcid:0000-0002-8264-9713(Xiao Cheng)

关键词: 灯盏花乙素, 局灶性脑缺血损伤, 氧糖剥夺, NADPH氧化酶2, 活性氧, 缝隙连接蛋白43

Abstract:

Scutellarin, a bioactive flavone isolated from Scutellaria baicalensis, has anti-inflammatory, anti-neurotoxic, anti-apoptotic and anti-oxidative effects and has been used to treat cardiovascular and cerebrovascular diseases in China. However, the mechanisms by which scutellarin mediates neuroprotection in cerebral ischemia remain unclear. The interaction between scutellarin and nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) was assessed by molecular docking study, which showed that scutellarin selectively binds to NOX2 with high affinity. Cultures of primary astrocytes isolated from the cerebral cortex of neonatal Sprague-Dawley rats were pretreated with 2, 10 or 50 μM scutellarin for 30 minutes. The astrocytes were then subjected to oxygen/glucose deprivation by incubation for 2 hours in glucose-free Dulbecco’s modified Eagle’s medium in a 95% N2/5% CO2 incubator, followed by simulated reperfusion for 22 hours. Cell viability was assessed by cell counting kit-8 assay. Expression levels of NOX2, connexin 43 and caspase-3 were assessed by western blot assay. Reactive oxygen species were measured spectrophotometrically. Pretreatment with 10 or 50 μM scutellarin substantially increased viability, reduced the expression of NOX2 and caspase-3, increased the expression of connexin 43, and diminished the levels of reactive oxygen species in astrocytes subjected to ischemia-reperfusion. We also assessed the effects of scutellarin in vivo in the rat transient middle cerebral artery occlusion model of cerebral ischemia-reperfusion injury. Rats were given intraperitoneal injection of 100 mg/kg scutellarin 2 hours before surgery. The Bederson scale was used to assess neurological deficit, and 2,3,5-triphenyltetrazolium chloride staining was used to measure infarct size. Western blot assay was used to assess expression of NOX2 and connexin 43 in brain tissue. Enzyme-linked immunosorbent assay was used to detect 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal (4-HNE) and 3-nitrotyrosin (3-NT) in brain tissue. Immunofluorescence double staining was used to determine the co-expression of caspase-3 and NeuN. Pretreatment with scutellarin improved the neurological function of rats with focal cerebral ischemia, reduced infarct size, diminished the expression of NOX2, reduced levels of 8-OHdG, 4-HNE and 3-NT, and reduced the number of cells co-expressing caspase-3 and NeuN in the injured brain tissue. Furthermore,we examined the effect of the NOX2 inhibitor apocynin. Apocynin substantially increased connexin 43 expression in vivo and in vitro. Collectively, our findings suggest that scutellarin protects against ischemic injury in vitro and in vivo by downregulating NOX2,upregulating connexin 43, decreasing oxidative damage, and reducing apoptotic cell death.

Key words: nerve regeneration, scutellarin, cerebral ischemic injury, oxygen glucose deprivation/reoxygenation, nicotinamide adenine dinucleotide phosphate oxidase 2, reactive oxygen species, connexin 43, neural regeneration